Table 1.
Control ( n = 9316) | PCOM ( n = 2879) | PCOS ( n = 3775) | P value | |
---|---|---|---|---|
Age (y) | 29.19 ± 2.982,3 | 28.06 ± 3.0791 | 28.05 ± 3.0731 | < 0.001* |
BMI (kg/m2) | 22.36 ± 3.062,3 | 22.85 ± 3.311,3 | 24.34 ± 3.581,2 | < 0.001* |
T (ng/ml) | 0.24 ± 0.102,3 | 0.28 ± 0.101,3 | 1.18 ± 6.191,2 | < 0.001* |
AMH (ng/ml) | 2.92 ± 1.552,3 | 5.27 ± 2.551,3 | 7.55 ± 4.001,2 | < 0.001* |
LH/FSH | 0.77 ± 0.402,3 | 0.98 ± 0.551,3 | 1.68 ± 1.121,2 | < 0.001* |
Data were presented as the mean ± SD. PCOS Polycystic ovary syndrome, PCOM Polycystic ovary morphology, BMI Body mass index, T Testosterone, AMH Anti-Müllerian hormone, FSH Follicle stimulating hormone, LH Luteinizing hormone
*P: significant difference among the groups. 1P: significant difference from the control group; 2P: significant difference from the PCOM group; 3P: significant difference from the PCOS group